Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 40 Breast Neoplasms 23 Gliosarcoma 22 Esophageal Neoplasms 21 Prostatic Neoplasms 19 Carcinoma, Non-Small-Cell Lung 19 Pancreatic Neoplasms 15 Squamous Cell Carcinoma of Head and Neck 13 Rectal Neoplasms 13 Glioma 13 Brain Neoplasms 13 Uterine Cervical Neoplasms 12 Neoplasms 12 Lung Neoplasms 11 Head and Neck Neoplasms 11 Melanoma 10 Astrocytoma 10 Sarcoma 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Central Nervous System Neoplasms 8 Stomach Neoplasms 7 Lymphoma, Follicular 6 Esophageal Squamous Cell Carcinoma 6 Endometrial Neoplasms 6 Adenocarcinoma Of Esophagus 6 Oropharyngeal Neoplasms 5 Neoplasm Metastasis 5 Lymphoma 5 Carcinoma 5 Burkitt Lymphoma 5

Interventions

Imatinib Mesylate 3 Radiotherapy 2 Nivolumab 2 relatlimab 1 palbociclib 1 nilotinib 1 Surveys and Questionnaires 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Radiation 1 Proton Therapy 1 Photochemotherapy 1 Pemetrexed 1 Immunoglobulin G 1 Disulfides 1 Dihematoporphyrin Ether 1 Dasatinib 1 Cyclophosphamide 1 Blood Specimen Collection 1 Bacterial Load 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Chordoma × Radiation × Clear all

NCT03595228 2023-04-14

BN Brachyury and Radiation in Chordoma

Bavarian Nordic

Phase 2 Completed

29 enrolled 20 charts

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡